The aim of Clear Wave 3 was to reduce the rate of antipsychotic use in residents without a diagnosis of psychosis from baseline to the national average by April 30, 2019. 33 participating care homes across BC completed the collaborative. This technical report outlines in detail the evaluation results of Wave 3 which spanned from December 2017 to May 2019.
To view or download the summary report, click here.
This information is collected by Health Quality BC under section 26(c) of the Freedom of Information and Protection of Privacy Act and will be used to email you our newsletter. If you have any questions about the collection of this information, please contact: info@healthqualitybc.ca or 604.668.8210.
We would like to acknowledge that we are living and working with humility and respect on the traditional territories of the First Nations peoples of British Columbia.
We specifically acknowledge and express our gratitude to the keepers of the lands of the ancestral and unceded territory of the xʷməθkʷəy̓əm (Musqueam), Skwxwú7mesh (Squamish), and səl̓ilwətaɁɬ (Tsleil-Waututh) Nations, where our main office is located.
We also recognize Métis people and Métis Chartered Communities, as well as the Inuit and urban Indigenous peoples living across the province on various traditional territories.